Minghui Pharmaceutical (hangzhou) Ltd

This study tests a new drug called MHB018A for people with active moderate-to-severe thyroid eye disease, a condition that causes eye bulging and discomfort. About 108 adults aged 18-75 will receive either the drug or a placebo every 4 weeks for 6 months. The main goal is to see …

This study tests a new medicine called MHB018A for people with long-term moderate-to-severe thyroid eye disease, which causes bulging eyes and discomfort. About 150 adults will receive either the drug or a placebo every 4 weeks for 6 months. The goal is to see if the drug reduces…

This study tests an experimental drug called MHB009C in 200 adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants receive the drug alone, and researchers monitor side e…

This study tests an injection called MHB018A for people with moderate-to-severe thyroid eye disease, a condition that can cause bulging eyes and discomfort. About 258 adults who completed a prior study will receive the drug for 24 weeks to see if it reduces eye bulging and preven…

This study tests a new drug called MHB046C in 200 adults with advanced solid tumors that no longer respond to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants receive the drug by IV and are closely monitored for side effects…

This study tests a new drug called MHB036C, given with other anti-cancer treatments, for people with advanced lung cancer that hasn't responded to standard therapies. The goal is to find the safest dose and see if it shrinks tumors. About 300 adults aged 18-75 with good performan…

This study tests whether combining two experimental drugs, MHB036C and MHB039A, can shrink or control advanced breast cancer and other solid tumors that have spread. About 210 adults aged 18 to 75 with measurable tumors will receive the combination. The goal is to see if the trea…

This study tests a new drug called MHB048C in 200 adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if it can shrink tumors. Participants receive the drug by IV and are monitored for side effects and tumor re…

This study tests a new drug called MHB042C in 200 adults with advanced solid tumors that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants will receive the drug intravenously and be closely monitored for…

This study tests two experimental drugs, MHB088C and MHB039A, given together to people with advanced solid tumors that have not responded to standard treatments. The goal is to find the safest dose and see if the combination can shrink tumors. About 116 adults will take part in t…